BIAFW BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM)
- 0.490
- -0.180-26.88%
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) News
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has closed a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies, Inc. (NASDAQ:BIAF) today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock in a registered
Here's Why We're A Bit Worried About BioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation
BioAffinity Technologies News Update
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, provides a summary of recent Company
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins BioAffinity Technologies' Medical and Scientific Advisory Board and Incorporates CyPath Lung Into Medical Practice
Lung Innovations Network, a patient-centered practice that offers comprehensive lung care to over 10,000 patients in central and western Pennsylvania, will incorporate CyPath Lung into its practice to aid in the detection of early-stage lung cancer.
BioAffinity Technologies Appoints Jamie Platt, Ph.D., to Its Board of Directors
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie
CMS Posts Final Payment Determination for BioAffinity Technologies' CyPath Lung Effective January 2024
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other lung diseases, today announced that the Centers for
BioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced the appointment
Press Release: BioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and six months ended June 30, 2023, and provided a business update.
BioAffinity Technologies (NASDAQ:BIAFW) Stock Price Down 14.7%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating)'s stock price was down 14.7% during mid-day trading on Tuesday . The stock traded as low as $0.26 and last traded at $0.26. Approximately 611
BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 3%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating)'s share price traded down 3% during mid-day trading on Friday . The company traded as low as $0.33 and last traded at $0.33. 101 shares trade
BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 15.8%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares dropped 15.8% during mid-day trading on Wednesday . The company traded as low as $0.30 and last traded at $0.38. Approximately 8,092
BioAffinity Technologies (NASDAQ:BIAFW) Stock Price Down 19.9%
Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) traded down 19.9% during mid-day trading on Thursday . The company traded as low as $0.03 and last traded at $0.26. 812 shares cha
BioAffinity Technologies (NASDAQ:BIAFW) Stock Price Down 7.6%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares fell 7.6% on Tuesday . The stock traded as low as $0.35 and last traded at $0.49. 9,877 shares changed hands during trading, a declin
BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants
bioAffinity Technologies, Inc. (NASDAQ:BIAF) (NASDAQ:BIAFW) today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warra
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace.
WallachBeth Capital Announce Pricing Of BioAffinity Technologies IPO At $6.125 Per Unit
PRNewswire 1-Sep-2022 1:02 PMJERSEY CITY, N.J., Sept. 1, 2022 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that
Analysis
Price Target
No Data
